Clinical Features and Outcomes of Subacute Thyroiditis in Thai Patients


  • Yotsapon Thewjitcharoen Theptarin Hospital, Bangkok, Thailand
  • Krittiyawong Sirinate Diabetes and Thyroid Center, Theptarin Hospital, Bangkok
  • Butadej Siriwan Diabetes and Thyroid Center, Theptarin Hospital, Bangkok
  • Nakasatien Soontaree Diabetes and Thyroid Center, Theptarin Hospital, Bangkok
  • Himathongkam Thep Diabetes and Thyroid Center, Theptarin Hospital, Bangkok


Objective. To report the clinical characteristics and outcomes of subacute thyroiditis (SAT) patients in the Theptarin Hospital Thyroid Clinic.

Methodology. A retrospective review of medical records of SAT patients in the Theptarin Hospital from January 2007 to December 2013 was conducted. Clinical characteristics, laboratory findings, modes of treatment and complications were recorded.

Results. From January 2007 to December 2013, SAT was diagnosed in 149 patients, with the occurrence of SAT peaking in October and November. Of 115 patients who had complete follow-up data, mean age was 43.8±10.8 years, 88.7% were women, and SAT was preceded by an upper respiratory tract infection in 68.7%. Oral prednisolone was given in 83 cases (72.2%) at a median starting dose of 30 mg/da and was continued for a median duration of 49 days. Recurrence of SAT during the tapering period of oral prednisolone was observed in 12% of patients, resulting in reinitiation of steroid in 13% of patients for late recurrence. Transient and permanent hypothyroidism developed in 6.1% and 8.7% of patients respectively.

Conclusions. SAT in Thai patients showed seasonal clustering during October and November. Recurrences of SAT were common in the course of steroid treatment. SAT patients require careful follow-up during steroid treatment and long-term surveillance for thyroid dysfunction.


Download data is not yet available.

Author Biography

Yotsapon Thewjitcharoen, Theptarin Hospital, Bangkok, Thailand



Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26): 2646-55.

Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician. 2006;73(10):1769-76.

Samuels MH. Subacute, silent, and postpartum thyroiditis. Med Clin North Am 2012;96(2):223-33.

Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmstead County, Minnesota, study. J Clin Endocrinol Metab. 2003;88(5):2100-5.

Nishihara E, Ohye H, Amino N, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008;47(8):725-9.

Martino E, Buratti L, Bartalena L, et al. High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest. 1987;10(3):321-3.

Volpé R, Johnston MW. Subacute thyroiditis: A disease commonly mistaken for pharyngitis. Can Med Assoc J. 1957;77(4):297-307.

Erdem N, Erdogan M, Ozbek M et al. Demographic and clinical features of patients with subacute thyroiditis: Results of 169 patients from a single university center in Turkey. J Endocrinol Invest. 2007;30(7):546-50.

Chittaganpitch M, Supawat K, Olsen SJ, et al. Influenza viruses in Thailand: 7 years of sentinel surveillance data, 2004-2010. Influenza Other Respir Viruses. 2012;6(4): 276-83.

Hardoff R, Baron E, Sheinfeld M, et al. Localized manifestations of subacute thyroiditis presenting as solitary transient cold thyroid nodules. A report of 11 patients. Clin Nucl Med. 1995;20(11):981-4.

Amino N, Yabu Y, Miki T, et al. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves’ disease and destruction- induced thyrotoxicosis. J Clin Endocrinol Metab. 1981;53(1):113-6.

Bhasipol A, Sriphrapradang C. Patterns of thyroid hormones in patients with newly diagnosed thyrotoxicosis. Poster session presented at the 30th Annual Meeting of the Royal College of Physicians of Thailand, 2014 April 23-26, Pattaya, Thailand.

Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646.

Volpé R. The management of subacute (DeQuervain’s) thyroiditis. Thyroid. 1993;3(3):253-5.

Mizukoshi T, Noguchi S, Murakami T, et al. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone. Intern Med. 2001;40(4):292-5.

Kubota S, Nishihara E, Kudo T, et al. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan. Thyroid. 2013; 23(3):269-72.

Lio S, Pontecorvi A, Caruso M, et al. Transitory subclinical and permanent hypothyroidism in the course of subacute thyroiditis (de Quervain). Acta Endocrinol (Copenh). 1984;106(1):67-70.

Iitaka M, Momotani N, Ishii J, et al. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab. 1996;81(2):466-9.

Kramer AB, Roozendaal C, Dullaart RP. Familial occurrence of subacute thyroiditis associated with human leukocyte antigen-B35.Thyroid. 2004;14(7):544-7.

Wartofsky L, Schaaf M. Graves’ disease with thyrotoxicosis following subacute thyroiditis. Am J Med. 1987;83(4):761-4.

Fukata S, Matsuzuka F, Kobayashi A, et al. Development of Graves’ disease after subacute thyroiditis: two unusual cases. Acta Endocrinol (Copenh). 1992;126(6):495-6.

Minciullo PL, Ruggeri RM, Vita G, et al. Development of Hashimoto’s thyroiditis after subacute thyroiditis: An unusual patient. Thyroid. 2009;19(1):73-4.



How to Cite

Thewjitcharoen, Y., Sirinate, K., Siriwan, B., Soontaree, N., & Thep, H. (2015). Clinical Features and Outcomes of Subacute Thyroiditis in Thai Patients. Journal of the ASEAN Federation of Endocrine Societies, 30(2), 125. Retrieved from



Original Articles

Most read articles by the same author(s)

1 2 > >>